Literature DB >> 497801

Altered chromatin conformation in Alzheimer's disease.

D R Crapper, S Quittkat, U de Boni.   

Abstract

Chromatin samples were prepared from forty human brains. Chromatin was separated into a heavy heterochromatin fraction and two euchromatin fractions: intermediate euchromatin and light euchromatin. Employing a bacterial RNA polymerase as probe, only the euchromatin fractions were capable of RNA synthesis. In Control human brains, in brains of patients with dialysis dementia and in brains of elderly individuals without or with dementia of a type other than Alzheimer's disease, the euchromatin fractions accounted for about 75 per cent of the total DNA. In contrast, in brains of patients with advanced senile dementia or presenile dementia of the Alzheimer type, a wide range of euchromatin content was encountered with an average value of 55 per cent. Heterochromatization occurred in both neuron and glia enriched fractions suggesting that a major alteration in protein metabolism occurs in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497801     DOI: 10.1093/brain/102.3.483

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

1.  Time-dependent DNA condensation induced by amyloid beta-peptide.

Authors:  Haijia Yu; Jinsong Ren; Xiaogang Qu
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

2.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 3.  Chapter 5. Nuclear actin-related proteins in epigenetic control.

Authors:  Richard B Meagher; Muthugapatti K Kandasamy; Elizabeth C McKinney; Eileen Roy
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

4.  PIWIL1 protein power targets tau therapy.

Authors:  Sandra-Fausia Soukup; Patrik Verstreken
Journal:  Nat Neurosci       Date:  2014-03       Impact factor: 24.884

5.  A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

6.  Alterations in protein synthetic capability of nerve cells in Alzheimer's disease.

Authors:  D M Mann; D Neary; P O Yates; J Lincoln; J S Snowden; P Stanworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

7.  Polyamine depletion is associated with altered chromatin structure in HeLa cells.

Authors:  R D Snyder
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

8.  Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

Authors:  D R Crapper; S Quittkat; S S Krishnan; A J Dalton; U De Boni
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

9.  Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.

Authors:  J A Doebler; W R Markesbery; A Anthony; S W Scheff; R E Rhoads
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 10.  Are there roles for brain cell senescence in aging and neurodegenerative disorders?

Authors:  Florence C C Tan; Emmette R Hutchison; Erez Eitan; Mark P Mattson
Journal:  Biogerontology       Date:  2014-10-11       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.